Zentree Investments Limited 13D and 13G filings for Orchard Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-09 09:19 am Purchase |
2022-12-31 | 13G | Orchard Therapeutics plc ORTX |
Zentree Investments Limited | 1,596,056 12.598% |
304,244 (+23.55%) |
Filing |
| 2022-12-20 06:01 am Purchase |
2022-12-15 | 13G | Orchard Therapeutics plc ORTX |
Zentree Investments Limited | 1,291,812 10.197% |
644,065 (+99.43%) |
Filing |
| 2022-09-09 10:11 am Purchase |
2022-09-01 | 13G | Orchard Therapeutics plc ORTX |
Zentree Investments Limited | 647,747 5.122% |
647,747 (New Position) |
Filing |